ProCE Banner Activity

CE / CME

Where We Want to Be: The Search for a Cure for HIV

Podcast Episodes

Hear from global experts Katharine J. Bar, MD; Krista L. Dong, MD; Karine Dubé, DrPH, MPhil; Richard Jefferys; Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS; and Angelina Namiba, on the current status of HIV cure research, including key concepts to understand and communicate when counseling patients, colleagues, and the broader community on HIV cure.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: December 11, 2023

Expiration: December 10, 2024

Share

Faculty

Katharine J. Bar

Katharine J. Bar, MD

Associate Professor of Medicine
Director, Penn CFAR Virus and Reservoirs Core
University of Pennsylvania
Philadelphia, Pennsylvania

Jennifer Blanchette

Jennifer Blanchette, PhD

Independent Contractor
Clinical Care Options
Colorado, United States

Krista L. Dong

Krista L. Dong, MD

Clinical Director, FRESH Cohort
Assistant Professor of Medicine
Massachusetts General Hospital
Harvard Medical School
Boston, Massachussetts

Karine Dubé

Karine Dubé, DrPH, MPhil

Associate Professor
UCSD School of Medicine
Division of Infectious Diseases and Global Public Health
San Diego, California

Richard Jefferys

Richard Jefferys

Basic Science, Vaccines & Cure Project Director
Treatment Action Group
New York, New York

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director
Doherty Institute
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Consultant Physician
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Melbourne, Australia

Angelina Namiba

Angelina Namiba

Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for persons with HIV.

Program Learning Goal

The goal of this program is to improve learners’ knowledge and competence regarding the evolving field of HIV care including current best practices in HIV service delivery, the potential role of emerging ART options, and key concepts in HIV cure research.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Better engage with HIV cure research in ways that span from PWH counselling to clinical trial participation, through a robust understanding of key concepts and potential interventions

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Katharine J. Bar, MD

Associate Professor of Medicine
Director, Penn CFAR Virus and Reservoirs Core
University of Pennsylvania
Philadelphia, Pennsylvania

Katharine J. Bar, MD: consultant/advisor/Speaker: AbbVie.

Jennifer Blanchette, PhD

Independent Contractor
Clinical Care Options
Colorado, United States

Jennifer Blanchette, PhD, has no relevant financial relationships to disclose.

Krista L. Dong, MD

Clinical Director, FRESH Cohort
Assistant Professor of Medicine
Massachusetts General Hospital
Harvard Medical School
Boston, Massachussetts

Krista L. Dong, MD: researcher: Gilead. 

Karine Dubé, DrPH, MPhil

Associate Professor
UCSD School of Medicine
Division of Infectious Diseases and Global Public Health
San Diego, California

Karine Dubé, DrPH, MPhil: consultant/advisor/speaker: Gilead Sciences.

Richard Jefferys,

Basic Science, Vaccines & Cure Project Director
Treatment Action Group
New York, New York

Richard Jefferys has no relevant financial relationships to disclose. 

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director
Doherty Institute
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Consultant Physician
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS: consultant/advisor/speaker: AbbVie, Efsam, Gilead, Immunocore, Merck, Vaxxinity, ViiV; safety monitoring committee: Gilead; researcher: Gilead, Merck.

Angelina Namiba,

Founder Member
4M Network of Mentor Mothers
London, United Kingdom

Angelina Namiba, has no financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 11, 2023, through December 10, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the evaluation questions online.

You must respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008176-0000-23-316-H02-P
Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.